Clinical Trials in Detroit

Showing 11061-11080 of 16,931 trials

Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth

NCT00103532

Risk behaviors and their associated adverse health outcomes are becoming increasingly problematic among HIV-infected youth. This study is being conducted to test whether a brief motivational enhancement (ME) intervention will help reduce health risk behaviors (drug and alcohol use, sexual risk behavior, poor adherence to medications) among HIV+ youth.

HIV Infection

University of North Carolina, Chapel Hill225 participantsStarted Mar 2005

Los Angeles, California, United States • Los Angeles, California, United States • Fort Lauderdale, Florida, United States +3 more locations

TERMINATEDPhase 2< 1 mile

Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery

NCT00459121

RATIONALE: Vandetanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving vandetanib together with chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This phase II trial is studying how well giving vandetanib together with carboplatin and paclitaxel works in treating patients with stage I, stage II, or stage III non-small cell lung cancer that can be removed by surgery.

Lung Cancer

Barbara Ann Karmanos Cancer Institute2 participantsStarted Jul 2007

Detroit, Michigan, United States

Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth

Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Find Trials by Condition in Detroit

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Whole-Body Cooling for Birth Asphyxia in Term Infants

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Early Diagnosis of Candidiasis in Premature Infants

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

PRET: Patients Prone to Recurrence After Endovascular Treatment

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

A Study of LY3113593 in Participants With Chronic Kidney Disease

Use of the VisuMax™ Femtosecond Laser

A Brief Educational Intervention to Improve Traumatic Brain Injury (TBI) Screening Outcomes

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia